UBS Group’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $45.7M | Buy |
|
|||||
|
2025
Q2 | $7.86M | Sell |
|
|||||
|
2025
Q1 | $42.6M | Buy |
|
|||||
|
2024
Q4 | $12.6M | Buy |
|
|||||
|
2024
Q3 | $8.25M | Buy |
|
|||||
|
2024
Q2 | $5.41M | Sell |
|
|||||
|
2024
Q1 | $4.27M | Buy |
|
|||||
|
2023
Q4 | $4.32M | Buy |
|
|||||
|
2023
Q3 | $1.87M | Buy |
|
|||||
|
2023
Q2 | $1.07M | Buy |
|
|||||
|
2023
Q1 | $746K | Buy |
|
|||||
|
2022
Q4 | $636K | Sell |
|
|||||
|
2022
Q3 | $850K | Buy |
|
|||||
|
2022
Q2 | $764K | Sell |
|
|||||
|
2022
Q1 | $5.47M | Buy |
|
|||||
|
2021
Q4 | $4.74M | Buy |
|
|||||
|
2021
Q3 | $741K | Sell |
|
|||||
|
2021
Q2 | $2.23M | Buy |
|
|||||
|
2021
Q1 | $989K | Buy |
|
|||||
|
2020
Q4 | $1.07M | Sell |
|
|||||
|
2020
Q3 | $731K | Sell |
|
|||||
|
2020
Q2 | $2.23M | Sell |
|
|||||
|
2020
Q1 | $3.78M | Buy |
|
|||||
|
2019
Q4 | $3.15M | Buy |
|
|||||
|
2019
Q3 | $2.18M | Buy |
|
|||||
|
2019
Q2 | $1.69M | Buy |
|
|||||
|
2019
Q1 | $801K | Sell |
|
|||||
|
2018
Q4 | $1.42M | Buy |
|
|||||
|
2018
Q3 | $835K | Sell |
|
|||||
|
2018
Q2 | $1.51M | Buy |
|
|||||
|
2018
Q1 | $906K | Sell |
|
|||||
|
2017
Q4 | $1.06M | Sell |
|
|||||
|
2017
Q3 | $1.47M | Buy |
|
|||||
|
2017
Q2 | $779K | Sell |
|
|||||
|
2017
Q1 | $754K | Sell |
|
|||||
|
2016
Q4 | $596K | Buy |
|
|||||
|
2016
Q3 | $464K | Sell |
|
|||||
|
2016
Q2 | $859K | Buy |
|
|||||
|
2016
Q1 | $526K | Sell |
|
|||||
|
2015
Q4 | $677K | Buy |
|
|||||
|
2015
Q3 | $421K | Buy |
|
|||||
|
2015
Q2 | $667K | Sell |
|
|||||
|
2015
Q1 | $688K | Sell |
|
|||||
|
2014
Q4 | $403K | Buy |
|